SG Americas Securities
CRL icon

SG Americas Securities’s Charles River Laboratories CRL Stock Holding History

SG Americas Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.96M Sell
17,453
-168,720
-91% -$30M ﹤0.01% 1193
2026
Q1 		$32.1M Buy
186,173
+4,395
+2% +$815K 0.03% 392
2025
Q4 		$36.3M Buy
+181,778
New +$33M 0.05% 296
2025
Q3 		– Sell
-1,462
Closed -$222K – 3414
2025
Q2 		$222K Sell
1,462
-265,740
-99% -$35.4M ﹤0.01% 2202
2025
Q1 		$40.2M Buy
267,202
+265,558
+16,153% +$44.5M 0.13% 109
2024
Q4 		$303K Sell
1,644
-554
-25% -$107K ﹤0.01% 1785
2024
Q3 		$433K Sell
2,198
-29,506
-93% -$6.13M ﹤0.01% 1813
2024
Q2 		$6.55M Buy
31,704
+15,342
+94% +$3.48M 0.04% 440
2024
Q1 		$4.43M Buy
16,362
+3,108
+23% +$742K 0.02% 586
2023
Q4 		$3.13M Sell
13,254
-5,786
-30% -$1.14M 0.03% 485
2023
Q3 		$3.73M Buy
19,040
+12,936
+212% +$2.66M 0.04% 402
2023
Q2 		$1.28M Buy
6,104
+2,114
+53% +$421K 0.01% 945
2023
Q1 		$805K Buy
+3,990
New +$904K 0.01% 1312
2022
Q4 		– Sell
-3,497
Closed -$688K – 3110
2022
Q3 		$688K Buy
3,497
+2,564
+275% +$554K 0.01% 1272
2022
Q2 		$200K Sell
933
-929
-50% -$227K ﹤0.01% 2673
2022
Q1 		$529K Sell
1,862
-55,996
-97% -$17.3M ﹤0.01% 1847
2021
Q4 		$21.8M Buy
57,858
+44,569
+335% +$17.3M 0.12% 124
2021
Q3 		$5.48M Sell
13,289
-17,199
-56% -$7.14M 0.03% 494
2021
Q2 		$11.3M Buy
30,488
+17,416
+133% +$5.82M 0.05% 304
2021
Q1 		$3.79M Sell
13,072
-9,180
-41% -$2.55M 0.02% 660
2020
Q4 		$5.56M Buy
22,252
+19,333
+662% +$4.6M 0.03% 445
2020
Q3 		$661K Sell
2,919
-13,308
-82% -$2.76M ﹤0.01% 1451
2020
Q2 		$2.83M Sell
16,227
-4,263
-21% -$680K 0.02% 621
2020
Q1 		$2.59M Buy
20,490
+16,971
+482% +$2.55M 0.02% 664
2019
Q4 		$538K Sell
3,519
-899
-20% -$124K ﹤0.01% 1710
2019
Q3 		$585K Sell
4,418
-24,610
-85% -$3.3M ﹤0.01% 1780
2019
Q2 		$4.12M Buy
29,028
+25,754
+787% +$3.49M 0.03% 635
2019
Q1 		$476K Sell
3,274
-1,306
-29% -$172K ﹤0.01% 1881
2018
Q4 		$518K Sell
4,580
-3,292
-42% -$412K ﹤0.01% 1839
2018
Q3 		$1.06M Sell
7,872
-3,194
-29% -$394K 0.01% 1635
2018
Q2 		$1.24M Sell
11,066
-2,515
-19% -$272K 0.01% 1257
2018
Q1 		$1.45M Sell
13,581
-3,043
-18% -$328K 0.01% 1069
2017
Q4 		$1.82M Buy
16,624
+9,932
+148% +$1.08M 0.02% 969
2017
Q3 		$723K Sell
6,692
-13,984
-68% -$1.44M 0.01% 1522
2017
Q2 		$2.09M Sell
20,676
-142,134
-87% -$13.1M 0.02% 865
2017
Q1 		$14.6M Buy
162,810
+159,496
+4,813% +$13.5M 0.13% 147
2016
Q4 		$252K Sell
3,314
-1,321
-29% -$100K ﹤0.01% 2176
2016
Q3 		$386K Sell
4,635
-11,160
-71% -$936K ﹤0.01% 1934
2016
Q2 		$1.3M Sell
15,795
-527
-3% -$43.4K 0.01% 1129
2016
Q1 		$1.24M Buy
16,322
+4,243
+35% +$314K 0.01% 1175
2015
Q4 		$971K Buy
+12,079
New +$871K 0.01% 1161
2015
Q3 		– Sell
-6,302
Closed -$443K – 2184
2015
Q2 		$443K Buy
6,302
+1,138
+22% +$84.2K ﹤0.01% 1541
2015
Q1 		$409K Buy
5,164
+500
+11% +$36.9K ﹤0.01% 1541
2014
Q4 		$297K Sell
4,664
-17
-0.4% -$1.07K ﹤0.01% 2078
2014
Q3 		$280K Sell
4,681
-18,403
-80% -$1.05M ﹤0.01% 1799
2014
Q2 		$1.24M Buy
23,084
+18,472
+401% +$1.01M 0.01% 1237
2014
Q1 		$278K Sell
4,612
-5,638
-55% -$329K ﹤0.01% 1790
2013
Q4 		$544K Sell
10,250
-11,765
-53% -$591K ﹤0.01% 1516
2013
Q3 		$1.02M Buy
22,015
+18,337
+499% +$841K ﹤0.01% 1260
2013
Q2 		$151K Buy
+3,678
New +$158K ﹤0.01% 1877

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SG Americas Securities's CRL Position: Q2 2026 in Review

SG Americas Securities reduced its Charles River Laboratories (CRL) stake by 91% in Q2 2026, selling an estimated $30M and leaving 17,453 shares worth $3.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

SG Americas Securities first reported a position in CRL in Q2 2013 and has held it in 50 quarters since. The position peaked at $40.2M in Q1 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • SG Americas Securities held 17,453 shares of Charles River Laboratories worth $3.96M as of Q2 2026.
  • SG Americas Securities sold 168,720 Charles River Laboratories shares in Q2 2026, an estimated $30M.
  • Charles River Laboratories made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1193 holding.
  • SG Americas Securities first reported a position in Charles River Laboratories in Q2 2013 and has held it in 50 quarters since.
  • SG Americas Securities's Charles River Laboratories position peaked at $40.2M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.